Hyun Bae
Förmögenhet: 15 256 $ per 2026-07-31
Förmögenhet: 15 256 $ per 2026-07-31
Dr. Hyun W.
Bae, MD, is an Independent Director at Kairos Pharma Ltd. and a Professor-Orthopaedic Surgery at Cedars-Sinai Medical Center.
He is on the Board of Directors at Kairos Pharma Ltd. Dr. Bae was previously employed as a Chief Medical Officer & Director by Prosidyan, Inc. He received his undergraduate degree from The Trustees of Columbia University in The City of New York and a doctorate degree from Yale University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
KAIROS PHARMA, LTD. 0,23 % | 2026-03-31 | 49 855 ( 0,23 % ) | 15 256 $ | 2026-07-31 |
| Företag | Position | Start |
|---|---|---|
| KAIROS PHARMA, LTD. | Direktör/Styrelseledamot | 2020-09-09 |
Cedars-Sinai Medical Center
Cedars-Sinai Medical Center Hospital/Nursing ManagementHealth Services Operates as a hospital | Företagsledare/Principal | - |
| Företag | Position | Slut |
|---|---|---|
Prosidyan, Inc.
Prosidyan, Inc. Industrial SpecialtiesProcess Industries Develops fiber-based bioactive glass products | Teknisk/Vetenskaplig/F&U Direktör | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cedars-Sinai Medical Center
Cedars-Sinai Medical Center Hospital/Nursing ManagementHealth Services Operates as a hospital | Health Services |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prosidyan, Inc.
Prosidyan, Inc. Industrial SpecialtiesProcess Industries Develops fiber-based bioactive glass products | Process Industries |
Kairos Pharma Ltd.
Kairos Pharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån